View More View Less
  • 1 Molecular Microbiology and Genomics Consultants, Tannenstrasse 7, 55576 Zotzenheim, Germany
Open access

A century ago, Alfred Nissle discovered that intentional intake of particular strains of Escherichia coli could treat patients suffering from infectious diseases. Since then, one of these strains became the most frequently used probiotic E. coli in research and was applied to a variety of human conditions. Here, properties of that E. coli Nissle 1917 strain are compared with other commercially available E. coli probiotic strains, with emphasis on their human applications. A literature search formed the basis of a summary of research findings reported for the probiotics Mutaflor, Symbioflor 2, and Colinfant. The closest relatives of the strains in these products are presented, and their genetic content, including the presence of virulence, genes is discussed. A similarity to pathogenic strains causing urinary tract infections is noticeable. Historic trends in research of probiotics treatment for particular human conditions are identified. The future of probiotic E. coli may lay in what Alfred Nissle originally discovered: to treat gastrointestinal infections, which nowadays are often caused by antibiotic-resistant pathogens.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1.

    Kaas RS , Friis C, Ussery DW, Aarestrup FM: Estimating variation within the genes and inferring the phylogeny of 186 sequenced diverse Escherichia coli genomes. BMC Genomics 13, 577 (2012)

    • Search Google Scholar
    • Export Citation
  • 2.

    Tannock GW (1995). Normal Microflora. An Introduction to Microbes Inhabiting the Human Body, Chapman and Hall, London, UK

  • 3.

    Caugant DA , Levin BR, Selander RK: Genetic diversity and temporal variation in the E. coli population of a human host. Genetics 98, 467490 (1981)

    • Search Google Scholar
    • Export Citation
  • 4.

    Sender R , Fuchs S, Milo R: Revised estimates for the number of human and bacteria cells in the body. Plos Biol 14(8), e1002533 (2016)

  • 5.

    Hill MJ , Drasar BS: The normal colonic bacterial flora. Gut 16, 318323 (1975)

  • 6.

    Zuo HJ , Xie ZM, Zhang WW, Li YR, Wang W, Ding XB, Pei XF: Gut bacteria alteration in obese people and its relationship with gene polymorphism. World, J Gastroenterol 17, 10761081 (2011)

    • Search Google Scholar
    • Export Citation
  • 7.

    Lagier JC , Hugon P, Khelaifia S, Fournier PE, La Scola B, Raoult D: The rebirth of culture in microbiology through the example of culturomics to study human gut microbiota. Clin Microbiol Rev 28, 237264 (2015)

    • Search Google Scholar
    • Export Citation
  • 8.

    Avershina E , Rudi K: Confusion about the species richness of human gut microbiota. Benef Microbes 6, 657659 (2015)

  • 9.

    Qin J , Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Doré J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J; MetaHIT Consortium, Bork P, Ehrlich SD, Wang J: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 5965 (2010)

    • Search Google Scholar
    • Export Citation
  • 10.

    Lodinová-Zádníková R , Sonnenborn U, Tlaskalová H: Probiotics and E. coli infections in man. Vet Q 20 Suppl 3, S7881 (1998)

  • 11.

    Sheshko V , Hejnova J, Rehakova Z, Sinkora J, Faldyna M, Alexa P, Felsberg J, Nemcova R, Bomba A, Sebo P: HlyA knock out yields a safer Escherichia coli A0 34/86 variant with unaffected colonization capacity in piglets. FEMS Immunol Med Microbiol 48, 257266 (2006)

    • Search Google Scholar
    • Export Citation
  • 12.

    Lodinová R , Jouja V, Lanc A: Influence of the intestinal flora on the development of immune reactions in infants. J Bacteriol 93, 797800 (1967)

    • Search Google Scholar
    • Export Citation
  • 13.

    Lodinová R , Jouja V, Lanc A: Experimentelle Besiedlung des Darmtrakts von Neugeborenen mit dem E. coli 083 und Untersuchungen über die Bildung von Antikorpern. Z Immunitaetsforsch 133, 229237 (1967)

    • Search Google Scholar
    • Export Citation
  • 14.

    Lodinová R , Wagner V: Development of faecal immunoglobulins and coproantibodies in infants after artificial oral colonization with E. coli 083. Experientia 26, 188 (1970)

    • Search Google Scholar
    • Export Citation
  • 15.

    Lodinová-Zádníková R , Slavíková M, Tlaskalová-Hogenová H, Adlerberth I, Hanson LA, Wold A, Carlsson B, Svanborg C, Mellander L: The antibody response in breastfed and non-breast-fed infants after artificial colonization of the intestine with Escherichia coli O83. Pediatr Res 29, 396399 (1991)

    • Search Google Scholar
    • Export Citation
  • 16.

    Lodinová-Zádníková R , Prokesová L, Tlaskalová H, Kocourková I, Zizka J, Stranák Z: Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies. Ceska Gynekol 69 Suppl 1, 9197 (2004)

    • Search Google Scholar
    • Export Citation
  • 17.

    Kocourková I , Žádníková R, Žižka J, Rosová V: Effect of oral application of a probiotic E. coli strain on the intestinal microbiota of children of allergic mothers during the first year of life. Folia Microbiol (Praha) 52, 189193 (2007)

    • Search Google Scholar
    • Export Citation
  • 18.

    Lodinová-Zádníková R , Cukrovská B, Stranák Z: Effect of care in a protected environment on the occurrence of nosocomial infections, mucosal colonization of pathogenic microbiota and development of indicators of immunity in premature infants. Ceska Gynekol 67 Suppl 1, 2328 (2002)

    • Search Google Scholar
    • Export Citation
  • 19.

    Hejnova J , Pages D, Rusniok C, Glaser P, Sebo P, Buchrieser C: Specific regions of genome plasticity and genetic diversity of the commensal Escherichia coli A0 34/86. Int, J Med Microbiol 296, 541546 (2006)

    • Search Google Scholar
    • Export Citation
  • 20.

    Jansen GJ , Wildeboer-Veloo AC, van der Waaij D, Degener JE: Escherichia coli as a probiotic? Infection 26, 232233 (1998)

  • 21.

    Möndel M , Schroeder BO, Zimmermann K, Huber H, Nuding S, Beisner J, Fellermann K, Stange EF, Wehkamp J: Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol 2, 166172 (2009)

    • Search Google Scholar
    • Export Citation
  • 22.

    Enck P , Zimmermann K, Menke G, Klosterhalfen S: Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E. coli preparation (DSM17252) compared to placebo. Z Gastroenterol 47, 209–214. (2009) Erratum in Z Gastroenterol 52, 64 (2014)

    • Search Google Scholar
    • Export Citation
  • 23.

    Martens U , Enck P, Zieseniss E: Probiotic treatment of irritable bowel syndrome in children. Ger Med Sci 8, Doc07 (2010)

  • 24.

    Kruis W , Chrubasik S, Boehm S, Stange C, Schulze J: A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome. Int, J Colorectal Dis 27, 467474 (2012)

    • Search Google Scholar
    • Export Citation
  • 25.

    Ford AC , Quigley EM, Lacy BE, Lembo AJ, Saito YA, Schiller LR, Soffer EE, Spiegel BM, Moayyedi P: Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am, J Gastroenterol 109, 15471561 (2014)

    • Search Google Scholar
    • Export Citation
  • 26.

    Wassenaar TM , Beimfohr C, Geske T, Zimmermann K: Voluntarily exposure to a single, high dose of probiotic Escherichia coli results in prolonged colonisation. Benef Microbes 5, 367375 (2014)

    • Search Google Scholar
    • Export Citation
  • 27.

    Wassenaar TM , Zschüttig A, Beimfohr C, Geske T, Auerbach C, Cook H, Zimmermann K, Gunzer F: Virulence genes in a probiotic E. coli product with a recorded long history of safe use. Eur, J Microbiol Immunol (Bp) 5, 8193 (2015)

    • Search Google Scholar
    • Export Citation
  • 28.

    Schütz E : Behandlung von Darmerkrankungen mit Mutaflor. Fortschr Med 107, 599602 (1989)

  • 29.

    Kruis W , Schütz E, Fric P, Fixa B, Judmaier G, Stolte M: Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 11, 853858 (1997)

    • Search Google Scholar
    • Export Citation
  • 30.

    Rembacken BJ , Snelling AM, Hawkey PM, Chalmers DM, Axon AT: Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet, 354, 635639 (1999)

    • Search Google Scholar
    • Export Citation
  • 31.

    Kruis W , Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J: Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53, 16171623 (2004)

    • Search Google Scholar
    • Export Citation
  • 32.

    Goel A , Mittal A, Evstatiev R, Nemeth M, Kruis W, Stolte M, Boland CR, Gasche C: In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis. Aliment Pharmacol Ther 30, 634642 (2009)

    • Search Google Scholar
    • Export Citation
  • 33.

    Henker J , Müller S, Laass MW, Schreiner A, Schulze J: Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z Gastroenterol 46, 874875 (2008)

    • Search Google Scholar
    • Export Citation
  • 34.

    Matthes H , Krummenerl T, Giensch M, Wolff C, Schulze J: Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN). BMC Complement Altern Med 10, 13 (2010)

    • Search Google Scholar
    • Export Citation
  • 35.

    Joeres-Nguyen-Xuan TH , Boehm SK, Joeres L, Schulze J, Kruis W: Survival of the probiotic Escherichia coli Nissle 1917 (EcN) in the gastrointestinal tract given in combination with oral mesalamine to healthy volunteers. Inflamm Bowel Dis 16, 256262 (2010)

    • Search Google Scholar
    • Export Citation
  • 36.

    Petersen AM , Mirsepasi H, Halkjær SI, Mortensen EM, Nordgaard-Lassen I, Krogfelt KA: Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial. J Crohns Colitis 8, 14981505 (2014)

    • Search Google Scholar
    • Export Citation
  • 37.

    Rolfe VE , Fortun PJ, Hawkey CJ, Bath-Hextall F: Probiotics for maintenance of remission in Crohn’s disease. Cochrane Database Syst Rev 4, CD004826 (2006)

    • Search Google Scholar
    • Export Citation
  • 38.

    Malchow HA : Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease? J Clin Gastroenterol 25, 653658 (1997)

    • Search Google Scholar
    • Export Citation
  • 39.

    Jensen SR , Fink LN, Nielsen OH, Brynskov J, Brix S: Ex vivo intestinal adhesion of Escherichia coli LF82 in Crohn’s disease. Microb Pathog 51, 426431 (2011)

    • Search Google Scholar
    • Export Citation
  • 40.

    Hernando-Harder AC , von Bünau R, Nadarajah M, Singer MV, Harder H: Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation. Dig Dis Sci 53, 443450 (2008)

    • Search Google Scholar
    • Export Citation
  • 41.

    Möllenbrink M , Bruckschen E: Behandlung der chronischen Obstipation mit physiologischen Escherichia coli-Bakterien. Ergebnisse einer klinischen Studie die Wirksamkeit und Verträglichkeit von mikrobiologischen The ra pie mit dem E. coli Stamm Nissle 1917 (Mutaflor). Med Klin (Munich) 89, 587593 (1994)

    • Search Google Scholar
    • Export Citation
  • 42.

    Lata J , Juránková J, Príbramská V, Fric P, Senkyrík M, Díte P, Kroupa R: Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis. Vnitr Lek 52, 215219 (2006)

    • Search Google Scholar
    • Export Citation
  • 43.

    Lata J , Novotný I, Príbramská V, Juránková J, Fric P, Kroupa R, Stiburek O: The effect of probiotics on gut flora, level of endotoxin and Child–Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur, J Gastroenterol Hepatol 19, 11111113 (2007)

    • Search Google Scholar
    • Export Citation
  • 44.

    Fric P , Zavoral M: The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon. Eur, J Gastroenterol Hepatol 15, 313315 (2003)

    • Search Google Scholar
    • Export Citation
  • 45.

    Tromm A , Niewerth U, Khoury M, Baestlein E, Wilhelms G, Schulze J, Stolte M: The probiotic E. coli strain Nissle 1917 for the treatment of collagenous colitis: first results of an open-label trial. Z Gastroenterol 42, 365369 (2004)

    • Search Google Scholar
    • Export Citation
  • 46.

    Lodinová-Zádniková R , Sonnenborn U: Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol Neonate 71, 224232 (1997)

    • Search Google Scholar
    • Export Citation
  • 47.

    Cukrowska B , LodInová-ZádnIková R, Enders C, Sonnenborn U, Schulze J, Tlaskalová-Hogenová H: Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand, J Immunol 55, 204209 (2002)

    • Search Google Scholar
    • Export Citation
  • 48.

    Henker J , Laass M, Blokhin BM, Bolbot YK, Maydannik VG, Elze M, Wolff C, Schulze J: The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. Eur, J Pediatr 166, 311318 (2007)

    • Search Google Scholar
    • Export Citation
  • 49.

    Goerg KJ , Schlörer E: Probiotische Therapie einer pseudomembranösen Kolitis: Kombination aus intestinaler Lavage und oraler Gabe von Escherichia coli. Dtsch Med Wochenschr 123, 12741278 (1998)

    • Search Google Scholar
    • Export Citation
  • 50.

    Dölle S , Berg J, Rasche C, Worm M: Tolerability and clinical outcome of coseasonal treatment with Escherichia coli strain Nissle 1917 in grass pollen-allergic subjects. Int Arch Allergy Immunol 163, 2935 (2014)

    • Search Google Scholar
    • Export Citation
  • 51.

    Tannock GW , Tiong IS, Priest P, Munro K, Taylor C, Richardson A, Schultz M: Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in longterm care facilities. J Med Microbiol 60, 366370 (2011)

    • Search Google Scholar
    • Export Citation
  • 52.

    Prilassnig M , Wenisch C, Daxboeck F, Feierl G: Are probiotics detectable in human feces after oral uptake by healthy volunteers? Wien Klin Wochenschr 119, 456462 (2007)

    • Search Google Scholar
    • Export Citation
  • 53.

    Adediran J , Leatham-Jensen MP, Mokszycki ME, Frimodt-Møller J, Krogfelt KA, Kazmierczak K, Kenney LJ, Conway T, Cohen PS: An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic. Infect Immun 82, 670682 (2014)

    • Search Google Scholar
    • Export Citation
  • 54.

    Lochs H : A question of survival? Interaction between probiotics and the gastrointestinal tract. Wien Klin Wochenschr 119, 441443 (2007)

    • Search Google Scholar
    • Export Citation
  • 55.

    Caselli M , Cassol F, Calò G, Holton J, Zuliani G, Gasbarrini A: Actual concept of “probiotics”: is it more functional to science or business? World, J Gastroenterol 19, 15271540 (2013)

    • Search Google Scholar
    • Export Citation
  • 56.

    Reister M , Hoffmeier K, Krezdorn N, Rotter B, Liang C, Rund S, Dandekar T, Sonnenborn U, Oelschlaeger TA: Complete genome sequence of the gram-negative probiotic Escherichia coli strain Nissle 1917. J Biotechnol 187, 106107 (2014)

    • Search Google Scholar
    • Export Citation
  • 57.

    Cress BF , Linhardt RJ, Koffas MA: Draft genome sequence of Escherichia coli strain Nissle 1917 (Serovar O6:K5:H1). Genome Announc, 28, 1(2), e0004713 (2013)

    • Search Google Scholar
    • Export Citation
  • 58.

    Jacobi CA , Malfertheiner P: Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium. Dig Dis 29, 600607 (2011)

    • Search Google Scholar
    • Export Citation
  • 59.

    Verna EC , Lucak S: Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol 3, 307319 (2010)

  • 60.

    Nissle A : Über die Grundlagen einer neuen ursächlichen Bekämpfung der pathologischen Darmflora. Deutsche Medizinische Wochenschrift 42, 11811184 (1916)

    • Search Google Scholar
    • Export Citation
  • 61.

    Pöhlmann C , Thomas M, Förster S, Brandt M, Hartmann M, Bleich A, Gunzer F: Improving health from the inside: use of engineered intestinal microorganisms as in situ cytokine delivery system. Bioengineered 4, 172179 (2013)

    • Search Google Scholar
    • Export Citation
  • 62.

    Nissle A : Die antagonistische Behandlung chronischer Darmstörungen mit Colibakterien. Med Klin 2, 2933 (1918)

  • 63.

    Ortuño Sahagún D , Márquez-Aguirre AL, Quintero-Fabián S, López-Roa RI, Rojas-Mayorquín AE: Modulation of PPAR by nutraceutics as complementary treatment for obesity-related disorders and inflammatory diseases. PPAR Res 2012, 318613 (2012)

    • Search Google Scholar
    • Export Citation
  • 64.

    Nissle A : Weiteres über Grundlagen und Praxis der Mutaflor-Behandlung. Deutsche Medizinische Wochenschrift 44, 18091813 (1925)

  • 65.

    Zyrek AA , Cichon C, Helms S, Enders C, Sonnenborn U, Schmidt MA: Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 9, 804816 (2007)

    • Search Google Scholar
    • Export Citation
  • 66.

    Nissle A : Weiteres ü ber die Mutaflorbehandlung unter besonderer Berü cksichtigung der chronischen Ruhr. Mü nchener Medizinische Wochenschrift 25, 678681 (1919)

    • Search Google Scholar
    • Export Citation
  • 67.

    Nissle A : Erläuterung über die Bedeutung der Kolondysbakterie und den Wirkungsmechanismus der Colitherapie (“Mutaflor”). Die Medizinische 4, 10171022 (1959)

    • Search Google Scholar
    • Export Citation
  • 68.

    Nissle A : Alte und neue Erfahrungen über Heilerfolge durch Sanierung der Dickdarmflora mit Mutaflor bei Magen-Darmkrankheiten. Medizinische Welt 29–30, 15191523 (1961)

    • Search Google Scholar
    • Export Citation
  • 69.

    Nissle A : Zur Klärung der Beziehungen zwischen Krankheitsursache, Symptomen und rationeller Therapie. Medizinische Welt 23, 12901294 (1966)

    • Search Google Scholar
    • Export Citation
  • 70.

    Tannock GW (2002): Probiotics and Prebiotics: Where are we going? Caister Academic Press, Norfolk, England

  • 71.

    Fishbein M : The aerogenic response of Escherichia coli and strains of Aerobacter in EC broth and selected sugar broths at elevated temperatures. Appl Microbiol 10, 7985 (1962)

    • Search Google Scholar
    • Export Citation
  • 72.

    Vassiliadis G , Destoumieux-Garzón D, Lombard C, Rebuffat S, Peduzzi J: Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47. Antimicrob Agents Chemother 54, 288297 (2010)

    • Search Google Scholar
    • Export Citation
  • 73.

    Barth S , Duncker S, Hempe J, Breves G, Baljer G, Bauerfeind R: Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization. J Appl Microbiol 107, 16971710 (2009)

    • Search Google Scholar
    • Export Citation
  • 74.

    Kleta S , Steinrück H, Breves G, Duncker S, Laturnus C, Wieler LH, Schierack P: Detection and distribution of probiotic Escherichia coli Nissle 1917 clones in swine herds in Germany. J Appl Microbiol 101, 13571366 (2006)

    • Search Google Scholar
    • Export Citation
  • 75.

    Schroeder B , Duncker S, Barth S, Bauerfeind R, Gruber AD, Deppenmeier S, Breves G: Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig Dis Sci 51, 724731 (2006)

    • Search Google Scholar
    • Export Citation
  • 76.

    Splichalova A , Trebichavsky I, Rada V, Vlkova E, Sonnenborn U, Splichal I: Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine. Clin Exp Immunol 163, 242249 (2011)

    • Search Google Scholar
    • Export Citation
  • 77.

    Schierack P , Kleta S, Tedin K, Babila JT, Oswald S, Oelschlaeger TA, Hiemann R, Paetzold S, Wieler LH: E. coli Nissle 1917 Affects Salmonella adhesion to porcine intestinal epithelial cells. PLoS One 6(2), e14712 (2011)

    • Search Google Scholar
    • Export Citation
  • 78.

    Kleta S , Nordhoff M, Tedin K, Wieler LH, Kolenda R, Oswald S, Oelschlaeger TA, Bleiss W, Schierack P: Role of F1C fimbriae, flagella, and secreted bacterial components in the inhibitory effect of probiotic Escherichia coli Nissle 1917 on atypical enteropathogenic E. coli infection. Infect Immun 82, 18011802 (2014)

    • Search Google Scholar
    • Export Citation
  • 79.

    Bureš J , Smajs D, Kvetina J, Förstl M, Smarda J, Kohoutová D, Kuneš M, Cyrany J, Tacheci I, Rejchrt S, Lesná J, Vorisek V, Kopácová M: Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle. World, J Gastroenterol 17, 609617 (2011)

    • Search Google Scholar
    • Export Citation
  • 80.

    Bureš J , Pejchal J, Kvetina J, Tichý A, Rejchrt S, Kuneš M, Kopácová M: Morphometric analysis of the porcine gastrointestinal tract in a 10-day high-dose indomethacin administration with or without probiotic bacteria Escherichia coli Nissle 1917. Hum Exp Toxicol 30, 19551962 (2011)

    • Search Google Scholar
    • Export Citation
  • 81.

    Smajs D , Bureš J, Smarda J, Chaloupková E, Kvetina J, Förstl M, Kohoutová D, Kuneš M, Rejchrt S, Lesná J, Kopácová M: Experimental administration of the probiotic Escherichia coli strain Nissle 1917 results in decreased diversity of E. coli strains in pigs. Curr Microbiol 64, 205210 (2012)

    • Search Google Scholar
    • Export Citation
  • 82.

    Yang X , Twitchell E, Li G, Wen K, Weiss M, Kocher J, Lei S, Ramesh A, Ryan EP, Yuan L: High protective efficacy of rice bran against human rotavirus diarrhea via enhancing probiotic growth, gut barrier function, and innate immunity. Sci Rep 5, 15004 (2015)

    • Search Google Scholar
    • Export Citation
  • 83.

    Duncker SC , Lorentz A, Schroeder B, Breves G, Bischoff SC: Effect of orally administered probiotic E. coli strain Nissle 1917 on intestinal mucosal immune cells of healthy young pigs. Vet Immunol Immunopathol, 111, 239250 (2006)

    • Search Google Scholar
    • Export Citation
  • 84.

    Splíchal I , Fagerhol MK, Trebichavský I, Splíchalová A, Schulze J: The effect of intestinal colonization of germ-free pigs with Escherichia coli on calprotectin levels in plasma, intestinal and bronchoalveolar lavages. Immunobiology 209, 681687 (2005)

    • Search Google Scholar
    • Export Citation
  • 85.

    Haverson K , Rehakova Z, Sinkora J, Sver L, Bailey M: Immune development in jejunal mucosa after colonization with selected commensal gut bacteria: a study in germ-free pigs. Vet Immunol Immunopathol 119, 243253 (2007)

    • Search Google Scholar
    • Export Citation
  • 86.

    Hejnova J , Dobrindt U, Nemcova R, Rusniok C, Bomba A, Frangeul L, Hacker J, Glaser P, Sebo P, Buchrieser C: Characterization of the flexible genome complement of the commensal Escherichia coli strain A0 34/86 (O83:K24:H31). Microbiology 151, 385398 (2005)

    • Search Google Scholar
    • Export Citation
  • 87.

    Willenbrock H , Hallin PF, Wassenaar TM, Ussery DW: Characterization of probiotic Escherichia coli isolates with a novel pan-genome microarray. Genome Biol 8(12), R267 (2007)

    • Search Google Scholar
    • Export Citation
  • 88.

    Zschüttig A , Auerbach C, Meltke S, Eichhorn C, Brandt M, Blom J, Goesmann A, Jarek M, Scharfe M, Zimmermann K, Wassenaar TM, Gunzer F: Complete sequence of probiotic Symbioflor 2 Escherichia coli strain G3/10 and draft sequences of Symbioflor 2 E. coli strains G1/2, G4/9, G5, G6/7, and G8. Genome Announc 3(2), pii: e0133014 (2015)

    • Search Google Scholar
    • Export Citation
  • 89.

    Grozdanov L , Raasch C, Schulze J, Sonnenborn U, Gottschalk G, Hacker J, Dobrindt U: Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J Bacteriol 186, 54325441 (2004)

  • 90.

    Sun J , Gunzer F, Westendorf AM, Buer J, Scharfe M, Jarek M, Gössling F, Blöcker H, Zeng AP: Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data. J Biotechnol 117, 147161 (2005)

    • Search Google Scholar
    • Export Citation
  • 91.

    Vejborg RM , Friis C, Hancock V, Schembri MA, Klemm P: A virulent parent with probiotic progeny: comparative genomics of Escherichia coli strains CFT073, Nissle 1917 and ABU 83972. Mol Genet Genomics 283, 469484 (2010)

    • Search Google Scholar
    • Export Citation
  • 92.

    Hancock V , Vejborg RM, Klemm P: Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073, comparison of transcriptomes, growth and biofilm formation. Mol Genet Genomics 284, 437454 (2010)

    • Search Google Scholar
    • Export Citation
  • 93.

    Olier M , Marcq I, Salvador-Cartier C, Secher T, Dobrindt U, Boury M, Bacquié V, Pénary M, Gaultier E, Nougayrède JP, Fioramonti J, Oswald E: Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity. Gut Microbes 3, 501609 (2012)

    • Search Google Scholar
    • Export Citation
  • 94.

    Ewers C , Li G, Wilking H, Kiessling S, Alt K, Antáo EM, Laturnus C, Diehl I, Glodde S, Homeier T, Böhnke U, Steinrück H, Philipp HC, Wieler LH: Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: how closely related are they? Int, J Med Microbiol 297, 163176 (2007)

    • Search Google Scholar
    • Export Citation
  • 95.

    Mitchell NM , Johnson JR, Johnston B, Curtiss R 3rd, Mellata M: Zoonotic potential of Escherichia coli isolates from retail chicken meat products and eggs. Appl Environ Microbiol 81, 11771187 (2015)

    • Search Google Scholar
    • Export Citation
  • 96.

    Nakonieczna A , Cooper CJ, Gryko R: Bacteriophages and bacteriophage-derived endolysins as potential therapeutics to combat Gram-positive spore forming bacteria. J Appl Microbiol 119, 620631 (2015)

    • Search Google Scholar
    • Export Citation
  • 97.

    Reissbrodt R , Hammes WP, dal Bello F, Prager R, Fruth A, Hantke K, Rakin A, Starcic-Erjavec M, Williams PH: Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. FEMS Microbiol Lett 290, 6269 (2009)

    • Search Google Scholar
    • Export Citation
  • 98.

    Rund SA , Rohde H, Sonnenborn U, Oelschlaeger TA: Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. Int, J Med Microbiol 303, 18 (2013)

    • Search Google Scholar
    • Export Citation
  • 99.

    Deriu E , Liu JZ, Pezeshki M, Edwards RA, Ochoa RJ, Contreras H, Libby SJ, Fang FC, Raffatellu M: Probiotic bacteria reduce Salmonella Typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14, 2637 (2013)

    • Search Google Scholar
    • Export Citation
  • 100.

    Conway T , Cohen PS: Commensal and pathogenic Escherichia coli metabolism in the gut. Microbiol Spectr 3(3) (2015)

  • 101.

    Matuskova Z , Anzenbacherova E, Vecera R, Tlaskalova-Hogenova H, Kolar M, Anzenbacher P: Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats. PLoS One 9(2), e87150 (2014)

    • Search Google Scholar
    • Export Citation
  • 102.

    Stritzker J , Weibel S, Seubert C, Götz A, Tresch A, van Rooijen N, Oelschlaeger TA, Hill PJ, Gentschev I, Szalay AA: Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility. Int, J Med Microbiol 300, 449456 (2010)

    • Search Google Scholar
    • Export Citation
  • 103.

    Zhang Y , Zhang Y, Xia L, Zhang X, Ding X, Yan F, Wu F: Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein. Appl Environ Microbiol 78, 76037610 (2012)

    • Search Google Scholar
    • Export Citation
  • 104.

    Hill PJ , Stritzker J, Scadeng M, Geissinger U, Haddad D, Basse-Lüsebrink TC, Gbureck U, Jakob P, Szalay AA: Magnetic resonance imaging of tumors colonized with bacterial ferritin-expressing Escherichia coli. PLoS One 6(10), e25409 (2011)

    • Search Google Scholar
    • Export Citation
  • 105.

    Mandal PK , Misra AK: Concise synthesis of the pentasaccharide O-antigen of Escherichia coli O83:K24:H31 present in the Colinfant vaccine. Glycoconj J 25, 713722 (2008)

    • Search Google Scholar
    • Export Citation
  • 106.

    Patzer SI , Baquero MR, Bravo D, Moreno F, Hantke K: The colicin G H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology 149, 25572570 (2003)

    • Search Google Scholar
    • Export Citation
  • 107.

    Zschüttig A , Zimmermann K, Blom J, Goesmann A, Pöhlmann C, Gunzer F: Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10. PLoS One 7(3), e33351 (2012)

    • Search Google Scholar
    • Export Citation

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2020 0 28 28
Jul 2020 0 20 37
Aug 2020 0 31 39
Sep 2020 0 35 34
Oct 2020 0 30 39
Nov 2020 0 48 51
Dec 2020 0 3 2